PEOPLE - Changes at Advantage West Midlands' medical technologies cluster opportunity group:
This article was originally published in Clinica
Executive Summary
Minivator (Kingswinford, West Midlands) managing director Mike Lord has been voted chairman of Advantage West Midlands' medical technologies cluster opportunity group (COG). He replaces MCS Medical's Warren Gray, who retired from the role in June. From its base in Aston Science Park, Birmingham, the COG's remit is to match industry capability to market opportunity and promote investment in healthcare in the West Midlands region of the UK.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.